Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions
Completed
Ranbaxy Laboratories Limited
N/A
2002-06-01
The objective of this study was to compare the single-dose relative bioavailability of
Ranbaxy and Schering (Claritin-D® 24 hour) Loratadine 10mg /Pseudoephedrine Sulfate 240 mg
Extended-Release Tablets, in a fully replicated design, under fasting conditions.
Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions
Completed
Ranbaxy Laboratories Limited
N/A
2002-06-01
The objective of this study was to compare the single-dose relative bioavailability of
Ranbaxy and Schering (Claritin-D® 24 hour) 10 mg Loratadine/240 mg Pseudoephedrine Sulfate
Extended-Release Tablets, in a fully replicated design, under fed conditions.
Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis
Withdrawn
Azidus Brasil
Phase 3
2010-01-01
The primary objective of this study is to evaluate the clinical efficacy of the drug
Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin
D ® (loratadine + pseudoephedrine sulfate - Schering Plough) in patients with allergic
rhinitis by quantification of the scores of clinical parameters (signs and symptoms) and
laboratory (nasal flow) down through time.
A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
Completed
Bayer
Phase 4
2018-02-21
The purpose of the study is to evaluate changes in nasal airflow caused by loratadine 5
mg/pseudoephedrine sulfate 120 mg (Claritin D) tablet and fluticasone propionate 50 mcg per
spray nasal spray (Flonase) in subjects suffering from nasal congestion and other allergy
symptoms.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
